New drug could delay type 1 diabetes progression
Disease control
Recruiting now
This study tests a new drug called SAB-142 in people recently diagnosed with type 1 diabetes. The goal is to see if it can help the body keep making its own insulin for longer, slowing the disease. About 159 people aged 5 to 40 will receive either the drug or a placebo, and resea…
Phase: PHASE2 • Sponsor: SAb Biotherapeutics, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC